Novo Nordisk bags Rybelsus FDA approval for type 2 diabetes
Rybelsus FDA approval : Danish pharma company Novo Nordisk has bagged approval from the US Food and Drug Administration (FDA) for Rybelsus (semaglutide) oral tablets for its use in patients with type 2 diabetes. The FDA approval for Rybelsus is to improve control of blood sugar in addition to diet and exercise in adults having […]
The post Novo Nordisk bags Rybelsus FDA approval for type 2 diabetes appeared first on PharmaNewsDaily.com.